Merck Investors Cut Claims In Securities Fraud MDL
Several Allianz Global Investors units and Swedish national pension fund Fjarde AP-fonden have dismissed their claims in a multidistrict litigation claiming Merck & Co. and its executives misrepresented arthritis painkiller Vioxx...To view the full article, register now.
Already a subscriber? Click here to view full article